John Dow - Author on Grafa

Franklin Resources (NYSE:BEN), the global investment giant operating as Franklin Templeton, reported a slight uptick in preliminary assets under management (AUM) to $1.68 trillion as of December 31, 2025.

The results cap a complex quarter defined by robust organic growth in equity and alternatives, even as its Western Asset Management unit continued to grapple with institutional fixed-income outflows.

María Corina Machado says she is ready to lead Venezuela following the ousting of President Nicolás Maduro.

US lawmakers are preparing to debate the CLARITY Act as the crypto industry awaits long-sought regulatory clarity.

Morgan Stanley is seeking approval to launch Bitcoin and Solana ETFs as institutional interest in crypto investments grows.

Israel deepens ties with Somaliland as its foreign minister makes a historic visit following recognition.

Pro-crypto Senator Cynthia Lummis criticises reported Bitcoin sales by the US government despite plans for a strategic reserve.

Cognition Therapeutics (NASDAQ:CGTX) announced on January 6, 2026, the publication of peer-reviewed results from its Phase 2 SHIMMER study in the journal Alzheimer's & Dementia.

Alkermes (NASDAQ:ALKS) announced on January 6, 2026, that the U.S. FDA has granted Breakthrough Therapy Designation to alixorexton (formerly ALKS 2680) for the treatment of narcolepsy type 1 (NT1).

AngioDynamics (NASDAQ:ANGO) on Tuesday reported fiscal second-quarter results that highlighted continued momentum in its high-margin Med Tech portfolio, with overall net sales rising 8.8% year over year to $79.4 million for the period ended Nov. 30, 2025.

Calumet (NASDAQ:CLMT) released a preliminary fiscal 2025 update on Tuesday, signaling a major turning point in its effort to repair a stretched balance sheet.

Despite projecting a net loss between $69 million and $12 million, the Indianapolis-based specialty products maker highlighted a significant reduction in restricted debt and a "transformed" outlook for its high-growth renewable energy subsidiary.